Natera, Inc. Common Stock

NTRA Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
NTRA Income Statement
NTRA Balance Sheet
NTRA Cash Flow
Congress Trading

Recent trades of NTRA by members of U.S. Congress

Politician Type Traded
Josh Gottheimer House / D Purchase $1,001 - $15,000 Nov. 20, 2024
Daniel S. Goldman House / D Sale $1,001 - $15,000 Apr. 10, 2023
Daniel S. Goldman House / D Purchase $1,001 - $15,000 Mar. 06, 2023
Bill Hagerty Senate / R Sale (Partial) $1,001 - $15,000 Apr. 20, 2021
NTRA Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
NTRA Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
NTRA Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by NTRA's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $39,000 Oct 17, 2024 Issue: Medicare/Medicaid Health Issues
  • $39,000 Jul 18, 2024 Issue: Medicare/Medicaid Health Issues
  • $39,000 Apr 15, 2024 Issue: Medicare/Medicaid Health Issues
  • $26,000 Jan 23, 2024 Issue: Medicare/Medicaid Health Issues
  • $19,500 Oct 16, 2023 Issue: Medicare/Medicaid Health Issues
  • $19,500 Jul 18, 2023 Issue: Medicare/Medicaid Health Issues
  • $19,500 Jan 26, 2023 Issue: Medicare/Medicaid Health Issues
  • $10,000 Jan 20, 2023 Issue: Health Issues
  • $29,500 Oct 17, 2022 Issue: Medicare/Medicaid Health Issues
  • $34,500 Jul 12, 2022 Issue: Medicare/Medicaid Health Issues
  • $60,000 Apr 19, 2022 Issue: Health Issues
  • $34,500 Apr 11, 2022 Issue: Medicare/Medicaid Health Issues
  • $34,500 Jan 04, 2022 Issue: Medicare/Medicaid Health Issues
  • $34,500 Sep 30, 2021 Issue: Medicare/Medicaid Health Issues
  • $34,500 Aug 17, 2021 Issue: Medicare/Medicaid Health Issues
  • $19,500 Feb 27, 2021 Issue: Medicare/Medicaid Health Issues
  • $19,500 Jan 14, 2021 Issue: Health Issues
  • $19,500 Oct 06, 2020 Issue: Health Issues
  • $19,500 Jul 16, 2020 Issue: Health Issues
  • $19,500 Jul 06, 2020 Issue: Health Issues
  • $19,500 Feb 07, 2020 Issue: Health Issues
  • $6,500 Jul 25, 2019 Issue: Health Issues
  • $6,500 Jun 28, 2019 Issue: Health Issues
  • $6,500 Jun 28, 2019 Issue: Health Issues
  • $10,000 Oct 16, 2018 Issue: Health Issues
  • $10,000 Jul 19, 2018 Issue: Health Issues
  • $10,000 Jan 18, 2018 Issue: Medical/Disease Research/Clinical Labs Health Issues Medicare/Medicaid
  • $10,000 Oct 12, 2017 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
  • $10,000 Apr 17, 2017 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $30,000 Jan 05, 2017 Issue: Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $30,000 Oct 11, 2016 Issue: Medical/Disease Research/Clinical Labs Health Issues Medicare/Medicaid
  • $10,000 Jul 15, 2016 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues
  • $20,000 Jan 21, 2016 Issue: None
  • $20,000 Oct 15, 2015 Issue: Health Issues
Corporate Lobbying

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Methods for non-invasive prenatal ploidy calling Nov. 26, 2024
  • Patent Title: Methods for lung cancer detection Nov. 19, 2024
  • Patent Title: Methods for simultaneous amplification of target loci Oct. 08, 2024
  • Patent Title: Method for non-invasive prenatal testing using parental mosaicism data Sep. 24, 2024
  • Patent Title: Assessing graft suitability for transplantation Sep. 10, 2024
  • Patent Title: System and method for cleaning noisy genetic data and determining chromosome copy number Aug. 20, 2024
  • Patent Title: Methods for cancer detection and monitoring Jul. 02, 2024
  • Patent Title: Methods for non-invasive prenatal ploidy calling Jun. 25, 2024
  • Patent Title: Methods and compositions for determining ploidy Apr. 02, 2024
  • Patent Title: Methods for simultaneous amplification of target loci Mar. 26, 2024
  • Patent Title: Materials and methods for processing blood samples Mar. 19, 2024
  • Patent Title: Methods for amplification of cell-free dna using ligated adaptors and universal and inner target-specific primers for multiplexed nested pcr Sep. 05, 2023
  • Patent Title: Materials and methods for processing blood samples Jul. 25, 2023
  • Patent Title: Methods for amplification of cell-free dna using ligated adaptors and universal and inner target-specific primers for multiplexed nested pcr Feb. 28, 2023
  • Patent Title: Detecting mutations and ploidy in chromosomal segments Dec. 20, 2022
  • Patent Title: Compositions and methods for identifying nucleic acid molecules Dec. 20, 2022
  • Patent Title: Methods for simultaneous amplification of target loci Dec. 13, 2022
  • Patent Title: Methods for detection of donor-derived cell-free dna Dec. 13, 2022
  • Patent Title: Methods for simultaneous amplification of target loci Dec. 06, 2022
  • Patent Title: Compositions and methods for identifying nucleic acid molecules Dec. 06, 2022
  • Patent Title: Detecting mutations and ploidy in chromosomal segments Nov. 01, 2022
  • Patent Title: Methods for preparing a dna fraction from a biological sample for analyzing genotypes of cell-free dna Oct. 25, 2022
  • Patent Title: Methods and compositions for determining ploidy Oct. 25, 2022
  • Patent Title: Methods for simultaneous amplification of target loci Oct. 04, 2022
  • Patent Title: Methods for preparing a dna fraction from a biological sample for analyzing genotypes of cell-free dna Sep. 20, 2022
  • Patent Title: Detecting mutations and ploidy in chromosomal segments Sep. 20, 2022
  • Patent Title: Methods and compositions for determining ploidy Sep. 20, 2022
  • Patent Title: Detecting mutations and ploidy in chromosomal segments Aug. 16, 2022
  • Patent Title: Detecting mutations and ploidy in chromosomal segments Aug. 09, 2022
  • Patent Title: Methods for non-invasive prenatal paternity testing Aug. 09, 2022
  • Patent Title: Methods for simultaneous amplification of target loci Jul. 19, 2022
  • Patent Title: Detecting mutations and ploidy in chromosomal segments Jun. 28, 2022
  • Patent Title: Methods for amplification of cell-free dna using ligated adaptors and universal and inner target-specific primers for multiplexed nested pcr May. 31, 2022
  • Patent Title: Methods for non-invasive prenatal paternity testing May. 31, 2022
  • Patent Title: Methods for non-invasive prenatal ploidy calling May. 24, 2022
  • Patent Title: Methods for simultaneous amplification of target loci May. 17, 2022
  • Patent Title: Methods for non-invasive prenatal ploidy calling May. 17, 2022
  • Patent Title: Methods for nested pcr amplification of cell-free dna May. 10, 2022
  • Patent Title: Methods for non-invasive prenatal ploidy calling May. 03, 2022
  • Patent Title: Detecting mutations and ploidy in chromosomal segments May. 03, 2022
  • Patent Title: Detecting mutations and ploidy in chromosomal segments May. 03, 2022
  • Patent Title: Methods for simultaneous amplification of target loci Apr. 26, 2022
  • Patent Title: System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals Apr. 19, 2022
  • Patent Title: Methods for non-invasive prenatal ploidy calling Apr. 19, 2022
  • Patent Title: Methods for simultaneous amplification of target loci Mar. 29, 2022
  • Patent Title: Methods for non-invasive prenatal ploidy calling Dec. 14, 2021
  • Patent Title: Methods for non-invasive prenatal ploidy calling Nov. 23, 2021
  • Patent Title: Methods for non-invasive prenatal ploidy calling Nov. 23, 2021
  • Patent Title: Compositions and methods for identifying nucleic acid molecules Nov. 09, 2021
  • Patent Title: Methods for non-invasive prenatal ploidy calling Oct. 26, 2021
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of NTRA in WallStreetBets Daily Discussion

NTRA News

Recent insights relating to NTRA

CNBC Recommendations

Recent picks made for NTRA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NTRA

NTRA Top Shareholders
Shareholder
Shares Held
NTRA Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

NTRA Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view NTRA Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top